Bxq-350 In Newly Diagnosed Metastatic Colorectal Carcinoma (Asist)
Posted Date: Apr 26, 2024
- Investigator: Davendra Sohal
- Specialties: Cancer, Colorectal Cancer
- Type of Study: Drug
The study will assess the safety and efficacy of BXQ-350 plus modified FOLFOX7 (mFOLFOX7) and bevacizumab in participants who have newly diagnosed metastatic adenocarcinoma of the colon/rectum. The study will also evaluate if the administration of BXQ-350 with mFOLFOX7 and bevacizumab may diminish oxaliplatin induced sensory neurotoxicity, enabling participants to receive the total and planned doses of mFOLFOX7.
Criteria:
Null
Keywords:
Metastatic Colorectal Carcinoma, Neuropathy
For More Information:
Andrea Ordonez
NULL
cancer@uchealth.com